HIT Consultant December 7, 2022
Fred Pennic

What You Should Know:

Aetion, a provider of real-world evidence (RWE) technology and analytics, today announced that the FDA has extended Aetion’s contract to evaluate real-world data (RWD) involving COVID-19 medical countermeasures.

– Aetion will be expanding its work to evaluate data standardization in the context of COVID-19. Aetion has been collaborating with FDA since May 2020, providing validated software platform capabilities and RWD/E expertise to contribute to rapid evidence generation studies and advance methodological approaches...

Today's Sponsors


Today's Sponsor

Health Edge

Topics: Analytics, FDA, Govt Agencies, Healthcare System, Public Health / COVID, Technology
Predictive Analytics Tool Identifies Readmission Risk, Reduces Costs
Predictive analytics reduces hospital readmission at Corewell Health, study finds
UPMC backs healthcare analytics company in $50M financing round
Cosmos, Epic's massive EHR analytics platform, helps reduce new mother readmissions
HIMSSCast: Getting to better data for better predictive models

Share This Article